The addition of a second and third fracture-associated drug (FAD) is associated with an increase in hip fracture risk.
Significant changes in bone mass may occur after stroke and are more pronounced in the paretic limbs and during the first few months after the acute event.
Patients with atopic eczema have an increased risk for fracture, especially major osteoporotic fractures.
Researchers evaluated the association between trabecular bone loss and disease activity measures in patients with axial spondyloarthritis.
In a meta-analysis, researchers aimed to explore the association between denosumab and romosozumab and cardiovascular risk in patients with primary osteoporosis.
New recommendations provide guidance on prescribing bisphosphonates for patients with postmenopausal osteoporosis.
Obese and overweight older individuals who lose weight have lower bone mineral density (BMD) in their hips.
Short sleep duration is associated with lower bone mineral density (BMD) and a higher risk for osteoporosis among postmenopausal women.
This study was the first to evaluate both the prevalence of osteopenia and osteoporosis in a large cohort of patients with bronchiectasis and its relationship with other variables, including clinical, body composition and bone turnover, and inflammation markers.
Researchers performed a systematic review of clinical practice guidelines to identify nonpharmacologic recommendations for osteoporosis treatment.